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ABSTRACT
This study investigated the utility of an immuno-
chromatographic test (ICT) for the detection of
Streptococcus pneumoniae antigens in pleural ﬂuid.
Antigen was detected in 15 of 19 (79%) patients
with pneumococcal pneumonia. The ICT was
always negative in patients with non-pneumo-
coccal pneumonia, but was positive in three cases
with a non-infectious aetiology. In patients with
pneumonia for which no pathogen was identiﬁed,
antigen was detected in one of 24 pleural ﬂuids
tested. The ICT can be a valuable tool for the
management of pneumonia because it can detect
pneumococcal antigen in pleural effusion sam-
ples.
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Community-acquired pneumonia is a signiﬁcant
cause of morbidity and mortality, with the most
common aetiological agent in virtually all studies
being Streptococcus pneumoniae [1,2]. A deﬁnite
diagnosis of pneumococcal pneumonia requires
the isolation of S. pneumoniae from blood, pleural
ﬂuid effusions, trans-tracheal aspirate, trans-thor-
acic aspirate or samples obtained by protected
brush. However, blood and pleural ﬂuid cultures
are positive in only 30% of cases, and invasive
samples are not routinely or indiscriminately
performed because they require trained personnel
and may have adverse effects.
According to the guidelines of the Infectious
Diseases Society of America [1] and the American
Thoracic Society [2], any signiﬁcant pleural effu-
sion should be sampled to rule out the possibility
of empyema or complicated parapneumonic effu-
sion. Pleural ﬂuid examination should include
Gram’s stain and bacterial culture. However, the
diagnostic accuracy of these techniques may be
reduced by various factors, including preceding
antibiotic therapy. A rapid and accurate detection
method for pneumococcal antigen in pleural ﬂuid
effusions would therefore be most useful. Poly-
saccharide capsular antigen detection methods,
i.e., agglutination tests and counter-immunoelect-
rophoresis (CIE), have been used for antigen
detection in respiratory and other samples [3],
including pleural effusions [4]. An immunochro-
matographic test (ICT) (NOW Streptococcus pneu-
moniae Antigen Test; Binax, Portland, ME, USA)
has been developed to detect C polysaccharide
antigen (PnC) in urine samples [5,6]. The aim of
the present study was to determine the utility of
the ICT for the detection of S. pneumoniae-speciﬁc
antigens in pleural effusions.
In total, 91 pleural ﬂuid samples were included
in the study. Patients and samples were classiﬁed
into four groups: group 1 included 19 parapneu-
monic pleural ﬂuids from 16 patients (nine male
and seven female; mean age 54.26 years, range
18–91 years) who were diagnosed with pneumo-
coccal pneumonia; group 2 included seven para-
pneumonic pleural effusions from six patients
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(one male and ﬁve female; mean age 45.83 years,
range 31–69 years) with non-pneumococcal pneu-
monia aetiologies (one Pseudomonas aeruginosa,
one Morganella morganii and four pleural tuber-
culosis); group 3 included 24 pleural ﬂuids from
21 patients (18 male and three female; mean age
57.33 years, range 30–79 years) with pneumonia,
but with no identiﬁed pathogen (four patients
subsequently developed empyema, yielding two
Eschericha coli and two Peptostreptococcus spp.);
and group 4 included 41 pleural effusions from 40
patients (25 male and 15 female; mean age
66.62 years, range 34–88 years) with a non-infec-
tious aetiology (11 neoplasia, 17 secondary to
heart failure, six idiopathic pleural effusions, one
cirrhosis, two thoracic ascitis, and four secondary
to thoracic trauma).
S. pneumoniae was isolated from blood culture
with the BactAlert system (bioMe´rieux, Marcy-
L’Etoile, France). Microbiological examination of
the pleural effusions was performed by Gram’s
stain and bacterial culture, with identiﬁcation
based on standard microbiological criteria [7].
Pneumococcal antigen in pleural effusion was
detected by CIE using a pneumococcal omnise-
rum (Staten Serum Institut, Copenhagen, Den-
mark) that includes antibodies to 84 serotypes.
The technique was performed using a modiﬁca-
tion of a procedure described previously [8].
Urinary pneumococcal antigen was detected by
the ICT assay using concentrated urine according
to the instructions of the manufacturer. Pleural
ﬂuid specimens were collected and frozen at
) 20C until required, and were then thawed
immediately before being tested by the ICT assay.
Pleural ﬂuids were diluted 1 : 4 in EDTA 4%
w ⁄ v, boiled for 5 min, and then centrifuged at
3000 g for 15 min in order to minimise possible
non-speciﬁc reactions. The ICT was then used to
detect PnC in the supernatant of pleural ﬂuid
specimens. The results were read visually after
15 min by two independent trained investigators.
Table 1 summarises the results obtained for the
group 1 samples (i.e., patients who had been
diagnosed with pneumococcal pneumonia by
microbiological methods).
Overall results for the four groups are summa-
rised in Table 2. Among the 19 patients with
pneumococcal pneumonia, S. pneumoniae antigen
was detected in 15 cases by ICT, and was positive
for the only pleural effusion from which S.
pneumoniae was isolated. The ICT was always
negative in patients with non-pneumococcal
pneumonia, but was positive in three cases with
a non-infectious aetiology. The ICT was also
positive for one of 24 pleural ﬂuids from patients
with pneumonia for which no pathogen had been
isolated. Therefore, the overall sensitivity was
79% and the speciﬁcity was 93.6%.
Detection of pneumococcal antigen in urine by
the ICT test has proven useful in increasing the
number of diagnoses of pneumonia in adults
[5,6]. Nevertheless, there are several situations in
which the detection of urinary antigen is difﬁcult.
Obtaining large volumes of urine is not possible
for some patients, such as those who have oliguria
secondary to pneumonia, acute or chronic kidney
failure or altered mental status, and psychiatric
patients. In addition, up to 20% of results
obtained with urine specimens may be false-
negative [5].
Although the ICT was developed to detect
pneumococcal antigen in urine samples, it has
been adapted to other specimens, such as naso-
pharyngeal samples [9], otitis media effusions
[10], and cerebrospinal ﬂuid samples for the
diagnosis of pneumococcal meningitis [11], with
high sensitivity and speciﬁcity. Several studies
have examined the possibility of using other
methods to detect pneumococcal antigen in pleu-
Table 1. Results obtained by different methods in 19
pleural effusion samples from patients diagnosed with
pneumococcal pneumonia by microbiological methods
No. of
patients
Blood
culture
Urinary antigen
detection by ICT
Pleural effusion
Antigen
detection by CIE Culture
2 Positive Positive Negative Negative
1 Positive Positive Positive Negative
3 Negative Positive Positive Negative
12 Negative Positive Negative Negative
1 Negative Positive Negative Positive
CIE, counter-immunoelectrophoresis
ICT, immunochromatographic test
Table 2. Pneumococcal antigen detection in pleural effu-
sions by immunochromatographic test (ICT) among dif-
ferent groups of patients studied
Group of patients
Number of positive results/total
patients evaluated by ICT (%)
Pneumococcal pneumonia 15 ⁄ 19 (79)
Bacteraemia 3 ⁄ 3 (100)
Non-bacteraemia 12 ⁄ 16 (75)
Pneumonia with another aetiology 0 ⁄ 7 (0)
Pneumonia with no pathogen identiﬁed 1 ⁄ 24 (4.2)
Non-infectious aetiology 3 ⁄ 41 (7.3)
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ral effusions. Lampe et al. [4] used CIE with
pleural ﬂuid, and obtained favourable results in
comparison with conventional methods, while
Boersma et al. [12] obtained positive results in
eight of nine patients diagnosed with pneumo-
coccal pneumonia using a latex agglutination
method, with a speciﬁcity of 92%.
The present study demonstrates that the ICT
is a sensitive and speciﬁc test for detecting
pneumococcal antigen in pleural ﬂuid samples.
Antigen detection by ICT in pleural ﬂuid is
advantageous because results are obtained more
rapidly than with culture. Furthermore, the test
remains positive even if effective therapy has
already been started. Although the ICT was
developed to detect PnC from S. pneumoniae, it
has been shown previously that it is capable of
detecting capsular polysaccharide [13]. Therefore,
its sensitivity may vary according to the serotype
responsible for the pneumonia. In the present
study, only one serotype 3 isolate from a blood
culture was available for testing, and this was
detected efﬁciently.
The positive antigen result obtained in the
group of patients in whom no pathogen was
identiﬁed could be interpreted as a true-positive
result, based on the speciﬁcity of the test. It was
not possible in this case to obtain urine to perform
antigen detection; therefore, detection of pneu-
mococcal antigen in pleural ﬂuid may increase the
rate of diagnosis of pneumococcal pneumonia.
The three false-positive results in the group of
patients with a non-infectious aetiology are more
difﬁcult to explain. Two of these patients suffered
heart failure and one had neoplasia. However, a
concomitant lower respiratory tract infection was
documented clinically in all three cases, and the
possibility of a pneumococcal infection cannot be
eliminated. It was therefore concluded, based on
its sensitivity and speed, that the ICT may be a
valuable tool for detecting pneumococcal antigen
in pleural effusion samples and for the manage-
ment of pneumonia.
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